跳至主要内容
临床试验/NCT05210543
NCT05210543招募中不适用

Acquisition and Long-term Observation of Patients With Severe Allergic Reactions

Charite University, Berlin, Germany1 个研究点 分布在 1 个国家目标入组 20,000 人开始时间: 2007年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
20,000
试验地点
1
主要终点
Influence of risk factors

研究概览

简要总结

The Anaphylaxis Registry aims to assess data in a standardized form about symptoms, triggers, cofactors and therapy management from patients who experienced an anaphylactic reaction. This should improve diagnosis and long-term management of these life-threatening allergic reactions.

详细描述

A better understanding of the triggers and pathology of anaphylactic reactions could lead to a better diagnosis and prophylaxis to avoid the occurence of these life-threatening allergic reactions. This can be an advantage for affected persons regarding the their treatment and long-term management.

The Anaphylaxis Registry is an opportunity to gather these standardized data. The blood sampling is optional for the patient, however, it will contribute to the better understanding of the sensitization profile and possible mechanisms. Recent publications showed a correlation between an anaphylactic reaction and certain biomarkers. Those data will be validated in a larger number of population with identification of further biomarkers. It is presumed that certain genetic and epigenetic polymorphisms are abundant for patients who experienced an anaphylaxis.

To summarize, this study aims to contribute to a better understanding of the anaphylaxis in general, the diagnosis, and the prognosis with different severities. With the identification of a certain trigger, the obtained understanding may help to decrease the risk of or prevent future repeating reactions.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Anaphylactic reaction within the past 12 months

排除标准

  • 未提供

结局指标

主要结局

Influence of risk factors

时间窗: 10 years

Correlation between risk factors (age, epiphenomenon, comorbidity) and severity of anaphylaxis

次要结局

  • Current use of adrenaline(10 years)
  • Biomarkers(10 years)
  • Epiphenomenon(10 years)
  • Future use of adrenaline(10 years)
  • Country-specific differences in anaphylaxis handling(10 years)
  • Epigenetics(10 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Margitta Worm

Principal Investigator

Charite University, Berlin, Germany

研究点 (1)

Loading locations...

相似试验